UltraShape Ltd. announced today that the US Food and Drug Administration advised the company that it may submit a request for clearance of its Contour I system under the 510(k) regulation rather than as a Pre-Market Approval (PMA) as was previously advise

In January 2010, UltraShape launched Contour I™ ver3, a flexible multi-application platform for delivering UltraShape treatments. The RFVac is an accessory introduced for that platform. Combining radio frequency and vacuum capabilities, RFVac prepares the

SoproLIFE receive FDA clearance !